Barb’s 25-year background in finance and accounting management ranges from life science start-ups to commercial-stage companies. Prior to joining Danforth she served as CFO of Enterin, where she established the financial infrastructure to support the company’s progress in its clinical trials and preparing for the company’s capital raise. She previously held finance leadership roles at Egalet Corporation (Zyla Life Sciences), Sobi, Topaz Pharmaceuticals (acquired by Sanofi-Pasteur), Genaera Corporation and Vicuron Pharmaceuticals (acquired by Pfizer). Barb served as Director of Client Service at Resources Global Professionals (RGP). She began her career as an auditor at Deloitte.
In addition to her work at Danforth, Barb serves on the Board of Directors of Life Sciences Pennsylvania and the Board of Advisors of Life Science Cares Philadelphia.
Barb is a CPA and holds a BS in Accounting and MBA in Pharmaceutical and Healthcare Marketing from St. Joseph’s University.
- Served on a four-member team in leading a company through its successful IPO
- Established the finance infrastructure for a company’s first commercial product launch
- Participated in the sell-side diligence that led to a successful product sale to a strategic partner
- Led the financial migration from a contracted commercial organization to a new legal entity